Cambodia vs Eritrea: Hepatitis B surface antigen (HBsAg) prevalence
Cambodia
0.4%
in 2024
Eritrea
0.5%
in 2024
Cambodia rank
62nd
Eritrea rank
59th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Cambodia
- Eritrea
How they compare
Eritrea currently reports 0.5% against 0.4% in Cambodia, a difference of 0.1%.
That makes Eritrea's figure about 1.2 times Cambodia's.
Across all 10 years both countries report, Eritrea has been ahead every year.
Cambodia ranks 62nd and Eritrea ranks 59th of 194 countries.
Eritrea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cambodia | Eritrea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 0.6% | 0.2% | Eritrea |
| 2020s | 0.4% | 0.6% | 0.2% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Cambodia or Eritrea?
- Eritrea, at 0.5% against 0.4% in Cambodia as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Cambodia and Eritrea?
- 0.1%, with Eritrea ahead.
- How many years of comparable data are there for Cambodia and Eritrea?
- 10 years are reported by both, from 2015 to 2024.
- How do Cambodia and Eritrea rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Cambodia ranks 62nd and Eritrea ranks 59th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.